Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion, Zambon SpA, Mallinckrodt, Incyte Corporation, GlaxoSmithKline, Mereo Biopharma, Genentech New York, USA, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bronchiolitis Obliterans Syndrome Market to Grow Substantially by 2032, Assesses DelveInsight | Key Players - OrphAI Therapeutics, Sanofi, Renovion,...

Bronchiolitis Obliterans Syndrome Pipeline Progresses With Novel, Innovative Therapies Expected to Embrace the Space in the Next Decade Los Angeles, USA, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Bronchiolitis Obliterans Syndrome Pipeline Progresses With Novel, Innovative Therapies Expected to Embrace the Space in the Next Decade  With...